New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
11:28 EDTMDCOThe Medicines Co. briefing documents mixed, says Jefferies
Jefferies views the briefing documents for The Medicines Co.'s cangrelor as mixed with one reviewer recommending against approval and one for approval. The firm thinks the dose and timing of the loading dose will be a key topic of discussion at the advisory meeting on Wednesday and keeps a Buy rating on The Medicines Co.
News For MDCO From The Last 14 Days
Check below for free stories on MDCO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 4, 2014
08:43 EDTMDCOPointState Capital reports 7.3% passive stake in The Medicines Co.
Subscribe for More Information
April 3, 2014
07:05 EDTMDCOThe Medicines Co. announces FDA BLA acceptance for Fibrocaps,
The Medicines Co. announced that the U.S. Food and Drug Administration has accepted the filing of a biologic license application for the investigational hemostatic agent Fibrocaps, a dry powder formulation of fibrinogen and thrombin being developed to aid in hemostasis during surgery, where control of mild or moderate bleeding by conventional means is ineffective or impractical. The FDA action date for Fibrocaps is January 31, 2015.
April 2, 2014
10:00 EDTMDCOOn The Fly: Analyst Downgrade Summary
ArcelorMittal (MT) downgraded to Neutral from Outperform at Credit Suisse... Essex Property Trust (ESS) downgraded to Neutral from Buy at Goldman... Healthstream (HSTM) downgraded to Market Perform from Outperform at Northland... Imperial Oil (IMO) downgraded to Underperform from Neutral at BofA/Merrill... Nordion (NDZ) downgraded to Hold from Buy at Canaccord... The Medicines Co. (MDCO) downgraded to Neutral from Overweight at Piper Jaffray... U.S. Bancorp (USB) downgraded to Hold from Buy at Sandler O'Neill... Old National Bancorp (ONB) downgraded to Hold from Buy at Sandler O'Neill... Edison International (EIX) downgraded to Hold from Buy at Argus.
06:25 EDTMDCOThe Medicines Co. downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray downgraded The Medicines Co. (MDCO) to Neutral after a court ruled the company failed to prove its patents were infringed by Hospira (HSP).

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use